Susan M. Podlogar - 11 Sep 2026 Form 4 Insider Report for Tevogen Inc. (TVGN)

Reporting relationship: Director
Issuer ticker: TVGN
Reported as of: 11 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Sep 2026, 20:05:30 UTC
Prior SEC filing: 10 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirti Desai, Attorney-in-Fact

Key filing fact

Susan M. Podlogar filed Form 4 for Tevogen Inc. (TVGN) on 15 Sep 2026.

Key facts

This page summarizes Susan M. Podlogar's Form 4 filing for Tevogen Inc. (TVGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2026, 20:05.

Change

Previous filing in this sequence was filed on 10 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001709959 Primary reporting owner

PODLOGAR SUSAN M

Relationship: Director
Address: C/O TEVOGEN BIO HOLDINGS INC., 15 INDEPENDENCE BLVD, STE 410, WARREN
Signature: /s/ Kirti Desai, Attorney-in-Fact
Signature date: 15 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TVGN transaction

Common Stock

Award

Transaction value
Shares: +75,000
Change %: +154%
Price: $0.000000^*
Shares after: 123,678
Date: 11 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates.